Skip to main content

Are you Dr. Yao?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 79 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    72780 Country Club Dr
    #100
    Rancho Mirage, CA 92270
    Phone+1 760-834-7900
    Fax+1 760-834-7901

Summary

  • Dr. Stephanie Yao, MD is a board certified internist in Rancho Mirage, California. She is currently licensed to practice medicine in California and Illinois. She is affiliated with Eisenhower Health.

Education & Training

  • Advocate Health Care/Advocate Illinois Masonic Medical Center
    Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 1994 - 1997
  • University of Santo Tomas
    University of Santo TomasClass of 1986

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2006 - 2025
  • IL State Medical License
    IL State Medical License 1994 - 2008
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2013

Press Mentions

  • AMDL, a Subsidiary of China Biotech Services, Is Exclusively Licensed to Distribute FDA Approved Lung & Colon Cancer Companion Diagnostic Assay in Several Asian Regions Including China
    AMDL, a Subsidiary of China Biotech Services, Is Exclusively Licensed to Distribute FDA Approved Lung & Colon Cancer Companion Diagnostic Assay in Several Asian Regions Including ChinaAugust 10th, 2021
  • Kronos Bio : To Highlight Progress Across Pipeline and Outline Growth Strategy at Virtual R&D Day Today
    Kronos Bio : To Highlight Progress Across Pipeline and Outline Growth Strategy at Virtual R&D Day TodayJune 7th, 2021
  • Kronos Bio Presents Preclinical Data for Oral CDK9 Inhibitor KB-0742 Demonstrating Sustained Inhibition of Tumor Growth in Multiple Cancers at AACR Annual Meeting 2021
    Kronos Bio Presents Preclinical Data for Oral CDK9 Inhibitor KB-0742 Demonstrating Sustained Inhibition of Tumor Growth in Multiple Cancers at AACR Annual Meeting 2021April 10th, 2021
  • Join now to see all